STAT+: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

Biotech founded by Daphne Koller makes stir on eve of JPM conference with new papers on drugs for cancer, ALS, liver disease; poaches new CMO from Pfizer.
Click here to view original post